MABVAX THERAPEUTICS HOLDINGS, INC. — Form D

MABVAX THERAPEUTICS HOLDINGS, INC. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-10. The offering totals $5.2M, of which $5.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Jim J AntonopoulosDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
Paul M MaierDirectorSan Diego, CA
Jeffrey V RavetchDirectorSan Diego, CA
Michael M WickDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA
Philip O LivingstonExecutive OfficerSan Diego, CA
Robert HoffmanDirectorHouston, TX
Paul ResnickExecutive OfficerLexington, MA
Jeffrey EisenbergDirectorFramingham, MA
Paul V MaierDirectorDeer Park, IL
Paul MaierDirectorEL CAJON, CA
THOMAS VARVARODirectorIRVINE, CA
Thomas C VarvaroDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA
Philip O LivingstonDirectorSan Diego, CA
Gregory P HansonExecutive OfficerSan Diego, CA
Paul W ResnickExecutive OfficerSan Diego, CA
Jeffrey F EisenbergDirectorSan Diego, CA
Paul W MaffuidExecutive OfficerSan Diego, CA
Philip LivingstonDirectorSan Diego, CA
Kenneth CohenDirectorSan Diego, CA
Gregory HansonDirectorSan Diego, CA
Gregory HansonExecutive OfficerSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2018-05-15D$860K$830K
2018-02-13D$2.8M$2.8M
2015-04-09D$15.0M$11.6M
2014-05-22D$4.6M$4.6M

More